Literature DB >> 24012779

Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics.

Paraskevi Salpea1, Constantine A Stratakis2.   

Abstract

Endocrine neoplasia syndromes feature a wide spectrum of benign and malignant tumors of endocrine and non-endocrine organs associated with other clinical manifestations. This study outlines the main clinical features, genetic basis, and molecular mechanisms behind two multiple endocrine neoplasia syndromes that share quite a bit of similarities, but one can be inherited whereas the other is always sporadic, Carney complex (CNC) and McCune-Albright (MAS), respectively. Spotty skin pigmentation, cardiac and other myxomas, and different types of endocrine tumors and other characterize Carney complex, which is caused largely by inactivating Protein kinase A, regulatory subunit, type I, Alpha (PRKAR1A) gene mutations. The main features of McCune-Albright are fibrous dysplasia of bone (FD), café-au-lait macules and precocious puberty; the disease is caused by activating mutations in the Guanine Nucleotide-binding protein, Alpha-stimulating activity polypeptide (GNAS) gene which are always somatic. We review the clinical manifestations of the two syndromes and provide an update on their molecular genetics. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Carney complex; Endocrine neoplasia; GNAS; McCune–Albright; PRKAR1A

Mesh:

Year:  2013        PMID: 24012779      PMCID: PMC3943598          DOI: 10.1016/j.mce.2013.08.022

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  92 in total

1.  cAMP-dependent protein kinase regulatory subunit type IIbeta: active site mutations define an isoform-specific network for allosteric signaling by cAMP.

Authors:  Kerri M Zawadzki; Susan S Taylor
Journal:  J Biol Chem       Date:  2003-11-18       Impact factor: 5.157

2.  Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population.

Authors:  Anelia Horvath; Christoforos Giatzakis; Audrey Robinson-White; Sosipatros Boikos; Elizabeth Levine; Kurt Griffin; Erica Stein; Virginia Kamvissi; Payal Soni; Ioannis Bossis; Wouter de Herder; J Aidan Carney; Jérôme Bertherat; Peter K Gregersen; Elaine F Remmers; Constantine A Stratakis
Journal:  Cancer Res       Date:  2006-12-15       Impact factor: 12.701

Review 3.  GNAS -Related Loss-of-Function Disorders and the Role of Imprinting.

Authors:  Agnès Linglart; Stéphanie Maupetit-Méhouas; Caroline Silve
Journal:  Horm Res Paediatr       Date:  2013-03-29       Impact factor: 2.852

4.  Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors.

Authors:  Delphine Vezzosi; Rossella Libé; Camille Baudry; Marthe Rizk-Rabin; Anelia Horvath; Isaac Levy; Fernande René-Corail; Bruno Ragazzon; Constantine A Stratakis; Grégoire Vandecasteele; Jérôme Bertherat
Journal:  J Clin Endocrinol Metab       Date:  2012-09-20       Impact factor: 5.958

5.  Demonstration of McCune-Albright mutations in the liver of children with high gammaGT progressive cholestasis.

Authors:  E S Silva; S Lumbroso; M Medina; Y Gillerot; C Sultan; E M Sokal
Journal:  J Hepatol       Date:  2000-01       Impact factor: 25.083

Review 6.  The Carney complex (myxomas, spotty pigmentation, endocrine overactivity, and schwannomas).

Authors:  J A Carney
Journal:  Dermatol Clin       Date:  1995-01       Impact factor: 3.478

7.  An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesion.

Authors:  C D Malchoff; G Reardon; D C MacGillivray; H Yamase; A D Rogol; D M Malchoff
Journal:  J Clin Endocrinol Metab       Date:  1994-03       Impact factor: 5.958

8.  Association of the M1V PRKAR1A mutation with primary pigmented nodular adrenocortical disease in two large families.

Authors:  Alberto M Pereira; Frederik J Hes; Anelia Horvath; Sanne Woortman; Elizabeth Greene; Eirini Bimpaki; Anton Alatsatianos; Sosipatros Boikos; Johannes W Smit; Johannes A Romijn; Maria Nesterova; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-11-13       Impact factor: 5.958

9.  Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.

Authors:  Laure Cazabat; Rossella Libè; Karine Perlemoine; Fernande René-Corail; Nelly Burnichon; Anne-Paule Gimenez-Roqueplo; Laurence Dupasquier-Fediaevsky; Xavier Bertagna; Eric Clauser; Philippe Chanson; Jérôme Bertherat; Marie-Laure Raffin-Sanson
Journal:  Eur J Endocrinol       Date:  2007-07       Impact factor: 6.664

10.  A novel GNAS1 mutation, R201G, in McCune-albright syndrome.

Authors:  M Riminucci; L W Fisher; A Majolagbe; A Corsi; R Lala; C De Sanctis; P G Robey; P Bianco
Journal:  J Bone Miner Res       Date:  1999-11       Impact factor: 6.741

View more
  29 in total

Review 1.  [Soft tissue tumors in hereditary tumor syndromes].

Authors:  A Agaimy
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

2.  A giant? Think of genetics: growth hormone-producing adenomas in the young are almost always the result of genetic defects.

Authors:  Constantine A Stratakis
Journal:  Endocrine       Date:  2015-06-09       Impact factor: 3.633

Review 3.  Signs and genetics of rare cancer syndromes with gastroenterological features.

Authors:  William Bruno; Giuseppe Fornarini; Paola Ghiorzo
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

4.  Oral pigmentation in McCune-Albright syndrome.

Authors:  Dominique C Pichard; Alison M Boyce; Michael T Collins; Edward W Cowen
Journal:  JAMA Dermatol       Date:  2014-07       Impact factor: 10.282

5.  E pluribus unum? The main protein kinase A catalytic subunit (PRKACA), a likely oncogene, and cortisol-producing tumors.

Authors:  Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2014-10       Impact factor: 5.958

6.  Rare diseases in clinical endocrinology: a taxonomic classification system.

Authors:  G Marcucci; L Cianferotti; P Beck-Peccoz; M Capezzone; F Cetani; A Colao; M V Davì; E degli Uberti; S Del Prato; R Elisei; A Faggiano; D Ferone; C Foresta; L Fugazzola; E Ghigo; G Giacchetti; F Giorgino; A Lenzi; P Malandrino; M Mannelli; C Marcocci; L Masi; F Pacini; G Opocher; A Radicioni; M Tonacchera; R Vigneri; M C Zatelli; M L Brandi
Journal:  J Endocrinol Invest       Date:  2014-11-07       Impact factor: 4.256

Review 7.  Pituitary gigantism: update on molecular biology and management.

Authors:  Maya B Lodish; Giampaolo Trivellin; Constantine A Stratakis
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-02       Impact factor: 3.243

8.  cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors.

Authors:  Graeme B Bolger; Mariana F Bizzi; Sergio V Pinheiro; Giampaolo Trivellin; Lisa Smoot; Mary-Ann Accavitti; Márta Korbonits; Antonio Ribeiro-Oliveira
Journal:  Endocr Relat Cancer       Date:  2016-05       Impact factor: 5.678

Review 9.  [The activating GNAS mutation : A survey of fibrous dysplasia, its associated syndromes, and other skeletal and extraskeletal lesions].

Authors:  H Ostertag; S Glombitza
Journal:  Pathologe       Date:  2018-03       Impact factor: 1.011

Review 10.  Mouse models of adrenocortical tumors.

Authors:  Kaitlin J Basham; Holly A Hung; Antonio M Lerario; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2015-12-08       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.